Google is betting $100 million on a brand-new telehealth stock.
And early investors are scoring triple-digit gains by scooping up these Pre-IPO shares.
Smart money investors from Silicon Valley and Wall Street don’t WAIT for a stock to go public. Instead, they grab private shares right BEFORE the IPO (click here to see how).
Last week’s IPO headlines were dominated by Snowflake (NYSE: SNOW). And that $3.4 billion IPO overshadowed a much smaller and more interesting deal . . .
That company is Amwell (NYSE: AMWL).
It’s a leading telehealth company that helps facilitate virtual doctor’s appointments.
The current pandemic means that more patients are trying telemedicine. That creates huge demand for telehealth technology that facilitates these online appointments.
Amwell is among the largest telehealth technology providers. It works with 2,000 hospitals, 55 health plans and 36,000 employers covering 80 million patients.
Amwell has seen a 1,000% increase in doctor visits . . . and a 77% increase in revenues in the first half of 2020!
A total of 5.6 million telehealth visits have taken place using Amwell technology. And more than one-half of those have taken place in the first half of 2020.
Google is a major technology partner providing cloud services. As part of this partnership, Google invested $100 million in Amwell’s IPO last week.
Why is Google investing in Amwell?
First, the investment helps secure the partnership between the companies. Making a huge investment assures that Amwell won’t switch to Amazon Web Services or another cloud platform.
Second, Google thinks that the telehealth technology investment will deliver a big return. That’s because IPOs are booming. Anything related to technology or cloud computing is soaring in price.
Purchasing shares let Google claim a sizable stake in the telehealth company – before the stock takes off (click here to secure your next Pre-IPO).
The timing of this IPO is ideal.
The company raised $742 million in an IPO last Thursday at a $4.5 billion valuation.
Shares jumped 28.2% in the first day of trading. And the stock has moved sideways since then
While IPO investors are seeing healthy gains . . .
It’s really the Pre-IPO investors who are scoring bigger profits.
In May, Amwell raised $194 million from investors. And while the company didn’t disclose the valuation – it was likely at a huge discount to the $18 IPO price.
The IPO market is booming.
Unfortunately, only extremely wealthy investors with +$10 million accounts can get IPO shares. And even then, you’ll need an account and connections to Goldman Sachs or JP Morgan.
That’s why I’m thrilled to share the billionaire’s Pre-IPO secret.
Because it allows EVERYONE to buy shares of an upcoming IPO – days, weeks or even months before the deal goes public.
Yours in Wealth,